Clearwater Acquires TECH LOCK

New York, NY—Clearwater, an operating company of Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”), announced today that it has completed the acquisition of TECH LOCK, an industry-leading provider of managed detection and response (MDR), and compliance services, in…

Altaris Closes Sale of Tivity Health Holding

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the successful sale of its holdings in Tivity Health (“Tivity”) following closing of the acquisition of Tivity for $32.50 per share. As a…

Altaris Appoints Phil Smith as Operating Partner

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) is pleased to announce the appointment of Phil Smith as an Operating Partner. Mr. Smith brings a broad range of experience across the healthcare industry and will leverage his…

Altaris Closes Acquisition of Veranova from Johnson Matthey

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it completed the acquisition of Veranova, formerly known as Johnson Matthey’s Health business, from Johnson Matthey PLC (LSE: JMAT) for total consideration of up to £325…

Altaris Acquires Intricon Corporation

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it completed the acquisition of Intricon Corporation (including affiliated entities, “Intricon”), a publicly traded company listed on the NASDAQ stock exchange under the ticker “IIN”. As a…

Rafael Torres Appointed Managing Director at Altaris

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) is pleased to announce the appointment of Rafael Torres as a Managing Director to lead the firm’s coverage of the life sciences & diagnostics sectors, effective January 1, 2022. Mr….

Altaris Acquires Meridian Medical Technologies from Pfizer

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it completed the acquisition of Meridian Medical Technologies (“Meridian”), a global leader in emergency response and health security solutions with a focus on complex drug-device combination…

Altaris Closes Sale of BK Medical

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has completed the sale of BK Medical to General Electric Company (NYSE: GE) for a cash purchase price of $1.45 billion. Headquartered in Boston and…

Altaris to Acquire Johnson Matthey’s Health Business

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to acquire Johnson Matthey Health (“JM Health”) from Johnson Matthey PLC (LSE: JMAT) for total consideration of £325 million. The…

Kindeva Commits to Sustainable Inhaler Production with New Manufacturing Investment

Loughborough, UK, and Saint Paul, MN, US—Kindeva Drug Delivery L.P. (Kindeva) has announced a long-term commitment to manufacture the next generation of pressurized metered-dose inhaler (pMDI) products using lower Global Warming Potential (GWP) propellants.

Altaris Announces Acquisition of Meridian Medical Technologies from Pfizer

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to acquire Meridian Medical Technologies (“Meridian”), a global leader in emergency response and health security solutions with a focus on…

Altaris Announces Sale of BK Medical

New York, NY—Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”) announced today that it has entered into an agreement to sell BK Medical to General Electric (“GE”) (NYSE:GE) for a cash purchase price of $1.45 billion. The transaction is expected…